# EDGAR Filing Document

**Accession Number:** 0000026172
**File Stem:** 0000026172-26-000004
**Filing Date:** 2026-2
**Character Count:** 98743
**Document Hash:** c6fe526424b2972e38cf77aebedeeaf0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000026172-26-000004.hdr.sgml**: 20260205

**ACCESSION NUMBER**: 0000026172-26-000004

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20260205

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260205

**DATE AS OF CHANGE**: 20260205

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CUMMINS INC
- **CENTRAL INDEX KEY:** 0000026172
- **STANDARD INDUSTRIAL CLASSIFICATION:** ENGINES & TURBINES [3510]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 350257090
- **STATE OF INCORPORATION:** IN
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-04949
- **FILM NUMBER:** 26600583

**BUSINESS ADDRESS:**
- **STREET 1:** 500 JACKSON ST
- **STREET 2:** BOX 3005 MAIL CODE 93050
- **CITY:** COLUMBUS
- **STATE:** IN
- **ZIP:** 47202-3005
- **BUSINESS PHONE:** 8123773842

**MAIL ADDRESS:**
- **STREET 1:** BOX 3005 MAIL CODE 93050
- **STREET 2:** 500
- **CITY:** COLUMBUS
- **STATE:** IN
- **ZIP:** 47202-3005

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CUMMINS ENGINE CO INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? cmi-20260205

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

![cumminslogoa02.jpg](cmi-20260205_g1.jpg)

**FORM 8-K** 

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report:** February 5, 2026

&nbsp;&nbsp;&nbsp;&nbsp;**CUMMINS INC.** 

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Indiana** | **1-4949** | **35-0257090** |
| (State or other Jurisdiction of<br>Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |

---

**500 Jackson Street**

**P. O. Box 3005** 

**Columbus, Indiana 47202-3005** 

(Principal Executive Office) (Zip Code)

Registrant's telephone number, including area code: (**812) 377-5000** 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Sections 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading symbol(s) | Name of each exchange on which registered |
| Common stock, $2.50 par value | CMI | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02. Results of Operations and Financial Condition.**

On February 5, 2026, Cummins Inc. ("Cummins," "the Company," "the registrant," "we," "our," or "us") issued the attached press release reporting its financial results for the fourth quarter of 2025, which is furnished herewith as Exhibit 99.

The information furnished pursuant to this Item 2.02, including Exhibit 99, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act.

**Item 9.01. Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;(d)Exhibits. - The exhibit below is furnished herewith:

**<u>Exhibit Index</u>**

---

| | |
|:---|:---|
| Exhibit No. | Description |
| <u>[Exhibit 99](cmi2025q48-kex99.htm)</u> | <u>[Press Release dated February 5, 2026](cmi2025q48-kex99.htm)</u> |
| Exhibit 104 | Cover Page Interactive Data File (the cover page Interactive Data File is embedded within the Inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 5, 2026

---

| |
|:---|
| CUMMINS INC. |
| **/s/ LUTHER E. PETERS** |
| Luther E. Peters<br>*Vice President - Controller*<br>*(Principal Accounting Officer)* |

---

## Ex-99

**EXHIBIT 99**

![earningsreleasea06.jpg](earningsreleasea06.jpg)

February 5, 2026

**Cummins Reports Strong Fourth Quarter and Full-Year 2025 Results, Records Charges Associated with Electrolyzer Business Strategic Review**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Fourth quarter revenues of $8.5 billion; GAAP**<sup>1</sup> **Net Income of $593 million, or 6.9% of sales**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **EBITDA**<sup>2</sup> **in the fourth quarter was 13.5% of sales; Diluted EPS of $4.27**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Fourth quarter results include $218 million, or $1.54 per diluted share, of charges related to the Electrolyzer business within Accelera, of which $175 million were non-cash charges**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Full-year 2025 revenues of $33.7 billion; GAAP** **Net Income of $2.8 billion, or 8.4% of sales**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **EBITDA for full year 2025 was 16.0% of sales; Diluted EPS of $20.50**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Full-year 2025 results include $458 million, or $3.28 per diluted share, of charges related to the Electrolyzer business within Accelera, of which $415 million were non-cash charges**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Full-year 2026 revenues expected to increase 3% to 8%; EBITDA expected to range between 17.0% and 18.0% of sales**

COLUMBUS, IND. - Cummins Inc. (NYSE: CMI) today reported fourth quarter and full-year 2025 results.

"Cummins delivered strong operational results in the fourth quarter and full year despite continued weakness in North America truck markets. Our Distribution and Power Systems segments achieved record full-year sales and profitability as a result of disciplined execution and robust demand for data center backup power," said Jennifer Rumsey, Chair and CEO of Cummins. "In the fourth quarter, we recorded charges related to our electrolyzer business within the Accelera segment, reflecting actions taken as part of a strategic review initiated in response to shifts in hydrogen adoption expectations. These decisions were aimed at streamlining operations and reducing ongoing costs in light of the weaker outlook for demand."

"2025 marked a historic year for Cummins as we made significant progress in advancing key strategic priorities while continuing to raise performance cycle over cycle. I am tremendously proud of our employees for their resiliency and commitment to delivering for our customers amid persistent market uncertainty and change. Our disciplined cost management, diversified portfolio and effective execution allowed us to deliver strong results despite this challenging environment," concluded Rumsey.

------

Fourth quarter 2025 revenues of $8.5 billion increased 1% from the same quarter in 2024. Sales in North America decreased 2% while international revenues increased 5%.

Net income attributable to Cummins in the fourth quarter was $593 million, or $4.27 per diluted share, compared to $418 million, or $3.02 per diluted share, in 2024. The current quarter results include charges related to the electrolyzer business within Accelera of $218 million, or $1.54 per diluted share. The fourth quarter of 2024 included Accelera reorganization actions of $312 million, or $2.14 per diluted share, which were primarily non-cash charges.

EBITDA in the fourth quarter was $1.2 billion, or 13.5% of sales, compared to $1.0 billion, or 12.1% of sales, a year ago. EBITDA for the fourth quarter of 2025 and the fourth quarter of 2024 included the charges noted above.

Full-year 2025 revenues of $33.7 billion decreased 1% from 2024. Sales in North America decreased 3% and international revenues increased 2% compared to 2024.

Net income for the full year 2025 was $2.8 billion, or $20.50 per diluted share, compared to $3.9 billion, or $28.37 per diluted share, in 2024. 2025 results included charges related to the electrolyzer business within Accelera of $458 million, or $3.28 per diluted share. 2024 results included the gain related to the separation of Atmus, net of transaction costs and other expenses, of $1.3 billion, or $9.28 per diluted share; charges related to Accelera reorganization actions of $312 million, or $2.12 per diluted share; and first quarter restructuring expenses of $29 million, or $0.16 per diluted share.

EBITDA in 2025 was $5.4 billion, or 16.0% of sales, compared to $6.3 billion, or 18.6% of sales, a year ago. EBITDA for 2025 and 2024 included the gains and charges noted above.

**2026 Outlook:** 

Based on its current forecast, Cummins projects full-year 2026 revenue to be in the range of up 3% to 8%, and EBITDA to be in the range of 17.0% and 18.0% of sales.

Cummins plans to continue generating strong operating cash flow and returns for shareholders and is committed to our long-term strategic goal of returning 50% of operating cash flow back to shareholders.

"In 2026, we anticipate that demand will be slightly better in the North America on-highway truck markets, particularly in the second half of the year, paired with continued strength in data center power generation markets. Cummins remains well-positioned to invest in future growth, deliver strong financial results and return cash to shareholders in 2026," said Rumsey.

**2025 Highlights:** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cummins increased its common stock cash dividend for the 16th straight year and returned a total of $1,055 million to shareholders through dividends.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cummins introduced the much-anticipated B7.2 and X10 engines as part of our Cummins HELM™ platforms. Alongside the X15, the X10 and B7.2 provide customers with a power solution to meet their unique operational requirements while maintaining the performance and reliability for which Cummins is known. The B7.2 will feature a slightly higher displacement and

------

is designed to be a global platform that creates flexibility for different applications and duty cycles. The X10 will replace both the L9 and X12 engine platforms to deliver a new level of performance, durability and efficiency for heavy and medium-duty customers. Both engines will be manufactured at Rocky Mount Engine Plant in North Carolina.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In February, Cummins announced the acquisition of assets of First Mode, a leader in retrofit hybrid solutions for mining and rail operations. The acquisition included hybrid mining and rail product lines, and the full IP portfolio of hybrid powertrain solutions. This technology represents the first commercially available retrofit hybrid system for mining equipment, significantly reducing total cost of ownership (TCO) while advancing decarbonization in operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Jennifer Rumsey was named one of Barron's Top CEOs of 2025. Jennifer was recognized for her visionary leadership and commitment to innovation and sustainability. The annual list features 26 leaders whose deft guidance has put their companies in a stronger competitive position.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cummins received several prestigious honors in 2025 recognizing the company's commitment to its people, culture and innovation. Of note, Forbes named Cummins one of America's Best Employers for Company Culture and one of America's best Employers for Engineers. Military Friendly® recognized the company as a Top Military-Friendly Employer, and Cummins was named a Best Place to Work for Disability Inclusion for the fifth consecutive year with a score of 100 on the Disability Equality Index®. Additionally, Cummins earned the Gold Bell Seal for Workplace Mental Health, received a Platinum Hermes Creative Award for its "It's OK" campaign, and was recognized for product and technical excellence with a Gold Product of the Year Award for the Centum™ Series generators and Powertrain Magazine's Alternative Engine of the Year Award for the next-generation X15 Off-Highway engine.

**Fourth quarter 2025 detail (all comparisons to same period in 2024):** 

**<u>Engine Segment</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sales - $2.6 billion, down 4%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Segment EBITDA - $263 million, or 10.1% of sales, compared to $367 million, or 13.5% of sales

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenues decreased 5% in North America and 4% in international markets due to lower medium-duty and heavy-duty truck demand in the United States and Mexico.

**<u>Components Segment</u>** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sales - $2.4 billion, down 7%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Segment EBITDA - $327 million, or 13.4% of sales, compared to $361 million, or 13.7% of sales

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenues in North America decreased 15% and international sales increased 4% primarily due to lower medium-duty and heavy-duty truck demand in the United States and stronger demand in Europe and China.

------

**<u>Distribution Segment</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sales - $3.3 billion, up 7%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Segment EBITDA - $495 million, or 15.1% of sales, compared to $400 million, or 13.0% of sales

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenues in North America increased 10% and international sales increased 2% driven by increased demand for power generation products, particularly for data center applications.

**<u>Power Systems Segment</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sales - $1.9 billion, up 11%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Segment EBITDA - $418 million, or 21.7% of sales, compared to $314 million, or 18.0% of sales

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenues in North America increased 15% and international sales increased 8% driven primarily by increased power generation demand, particularly for data center markets in North America, China and Asia Pacific.

**<u>Accelera Segment</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sales - $131 million, up 31%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Segment EBITDA loss - $374 million, which includes $218 million of charges related to the electrolyzer business within Accelera.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenues increased due to electrolyzer installation timing. The company remains committed to pacing and focusing its zero-emissions investments on the most promising paths in order to ensure long-term success as part of Cummins' Destination Zero strategy. These continued investments contributed to the EBITDA losses.

<sup>1</sup> Generally Accepted Accounting Principles

<sup>2</sup> Earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests

**About Cummins Inc.**

Cummins Inc., a global power leader, is committed to powering a more prosperous world. Since 1919, we have delivered innovative solutions that move people, goods and economies forward. Our five business segments—Engine, Components, Distribution, Power Systems and Accelera™ by Cummins—offer a broad portfolio, including advanced diesel, alternative fuel, electric and hybrid powertrains; integrated power generation systems; critical components such as aftertreatment, turbochargers, fuel systems, controls, transmissions, axles and brakes; and zero-emissions technologies like battery and electric powertrain systems. With a global footprint, deep technical expertise and an extensive service network, we deliver dependable, cutting-edge solutions tailored to our customers' needs, supporting them through the energy transition with our Destination Zero strategy. We create value for customers, investors and employees and strengthen communities through our corporate responsibility global priorities: education, equity and environment. Headquartered in Columbus, Indiana, Cummins employs approximately 70,000 people worldwide and earned $3.9 billion on $34.1 billion in sales in 2024. Learn more at https://www.cummins.com.

**Forward-looking disclosure statement**

Information provided in this release that is not purely historical are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our forecasts, guidance, preliminary results, expectations, hopes, beliefs and intentions on strategies regarding the future. These forward-looking statements include, without limitation, statements relating to our plans and expectations for our revenues and EBITDA. Our actual future results could differ materially from those projected in such forward-looking statements because of a number of factors, including, but not limited to: any adverse consequences from changes in tariffs and other trade disruptions; any adverse consequences resulting from entering into agreements with the U.S. Environmental Protection Agency, California Air Resources Board, the Environmental and Natural Resources Division of the U.S. Department of Justice and the

------

California Attorney General's Office to resolve certain regulatory civil claims regarding our emissions certification and compliance process for certain engines primarily used in pick-up truck applications in the U.S., which became final and effective in April 2024, including required additional mitigation projects, adverse reputational impacts and potential resulting legal actions; increased scrutiny from regulatory agencies, as well as unpredictability in the adoption, implementation and enforcement of emission standards around the world; evolving environmental and climate change legislation and regulatory initiatives; changes in international, national and regional trade laws, regulations and policies; changes in taxation; global legal and ethical compliance costs and risks; future bans or limitations on the use of diesel-powered products; raw material, transportation and labor price fluctuations and supply shortages; aligning our capacity and production with our demand; the actions of, and income from, joint ventures and other investees that we do not directly control; large truck manufacturers' and original equipment manufacturers' customers discontinuing outsourcing their engine supply needs or experiencing financial distress, or change in control; product recalls; variability in material and commodity costs; the development of new technologies that reduce demand for our current products and services; lower than expected acceptance of new or existing products or services; product liability claims; our sales mix of products; climate change, global warming, more stringent climate change regulations, accords, mitigation efforts, greenhouse gas regulations or other legislation designed to address climate change; our plan to reposition our portfolio of product offerings through exploration of strategic acquisitions, divestitures or exiting the production of certain product lines or product categories and related uncertainties of such decisions; increasing interest rates; challenging markets for talent and ability to attract, develop and retain key personnel; exposure to potential security breaches or other disruptions to our information technology (IT) environment and data security; the use of artificial intelligence in our business and in our products and challenges with properly managing its use; political, economic and other risks from operations in numerous countries including political, economic and social uncertainty and the evolving globalization of our business; competitor activity; increasing competition, including increased global competition among our customers in emerging markets; failure to meet sustainability expectations or standards, or achieve our sustainability goals; labor relations or work stoppages; foreign currency exchange rate changes; the performance of our pension plan assets and volatility of discount rates; the price and availability of energy; continued availability of financing, financial instruments and financial resources in the amounts, at the times and on the terms required to support our future business; and other risks detailed from time to time in our SEC filings, including particularly in the Risk Factors section of our 2024 Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are made only as of the date of this release and we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. More detailed information about factors that may affect our performance may be found in our filings with the SEC, which are available at https://www.sec.gov or at https://www.cummins.com in the Investor Relations section of our website.

***Presentation of Non-GAAP Financial Information***

*EBITDA is a non-GAAP measure used in this release and is defined and reconciled to what management believes to be the most comparable GAAP measure in a schedule attached to this release, except for forward-looking measures of EBITDA where a reconciliation to the corresponding GAAP measures is not available due to the variability, complexity and limited visibility of the non-cash items that are excluded from the non-GAAP outlook measure. Cummins presents this information as it believes it is useful to understanding the Company's operating performance, and because EBITDA is a measure used internally to assess the performance of the operating units.*

***Webcast information***

*Cummins management will host a teleconference to discuss these results today at 10 a.m. EDT. This teleconference will be webcast and available on the Investor Relations section of the Cummins website at www.cummins.com. Participants wishing to view the visuals available with the audio are encouraged to sign-in a few minutes prior to the start of the teleconference.*

------

**CUMMINS INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME**

**(Unaudited) (a)**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **December 31,** | **December 31,** |
|<br>**In millions, except per share amounts** | **2025** | **2024** |
| **NET SALES** | $**8536** | $8447 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | **6585** | 6413 |
| **GROSS MARGIN** | **1951** | 2034 |
| **OPERATING EXPENSES AND INCOME** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | **786** | 801 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research, development and engineering expenses | **350** | 356 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity, royalty and interest income from investees | **116** | 70 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expense, net | **118** | 215 |
| **OPERATING INCOME** | **813** | 732 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | **82** | 89 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income, net | **60** | 19 |
| **INCOME BEFORE INCOME TAXES** | **791** | 662 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | **171** | 217 |
| **CONSOLIDATED NET INCOME** | **620** | 445 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Net income attributable to noncontrolling interests | **27** | 27 |
| **NET INCOME ATTRIBUTABLE TO CUMMINS INC.** | $**593** | $418 |
| **EARNINGS PER COMMON SHARE ATTRIBUTABLE TO CUMMINS INC.** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $**4.29** | $3.04 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $**4.27** | $3.02 |
| **WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | **138.2** | 137.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | **139.0** | 138.4 |
| <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. | <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. | <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. |

---

------

**CUMMINS INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME**

**(Unaudited) (a)**

---

| | | |
|:---|:---|:---|
| | **Years ended December 31,** | **Years ended December 31,** |
|<br>**In millions, except per share amounts** | **2025** | **2024** |
| **NET SALES** | $**33670** | $34102 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | **25154** | 25663 |
| **GROSS MARGIN** | **8516** | 8439 |
| **OPERATING EXPENSES AND INCOME** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | **3125** | 3275 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research, development and engineering expenses | **1396** | 1463 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity, royalty and interest income from investees | **469** | 395 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expense, net | **439** | 346 |
| **OPERATING INCOME** | **4025** | 3750 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | **329** | 370 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income, net | **267** | 1523 |
| **INCOME BEFORE INCOME TAXES** | **3963** | 4903 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | **1006** | 835 |
| **CONSOLIDATED NET INCOME** | **2957** | 4068 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Net income attributable to noncontrolling interests | **114** | 122 |
| **NET INCOME ATTRIBUTABLE TO CUMMINS INC.** | $**2843** | $3946 |
| **EARNINGS PER COMMON SHARE ATTRIBUTABLE TO CUMMINS INC.** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $**20.62** | $28.55 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $**20.50** | $28.37 |
| **WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | **137.9** | 138.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | **138.7** | 139.1 |
| <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. | <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. | <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. |

---

------

**CUMMINS INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(Unaudited) (a)**

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
|<br>**In millions, except par value** | **2025** | **2024** |
| **ASSETS** |  |  |
| Current assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**2845** | $1671 |
| &nbsp;&nbsp;&nbsp;&nbsp;Marketable securities | **764** | 593 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash, cash equivalents and marketable securities | **3609** | 2264 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts and notes receivable, net | **5818** | 5181 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | **5822** | 5742 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | **1676** | 1565 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | **16925** | 14752 |
| Long-term assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, net | **6958** | 6356 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments and advances related to equity method investees | **2133** | 1889 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | **2224** | 2370 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other intangible assets, net | **2167** | 2351 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension assets | **1033** | 1189 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | **2552** | 2633 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $**33992** | $31540 |
| **LIABILITIES** |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable (principally trade) | $**3800** | $3951 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans payable | **313** | 356 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commercial paper | **353** | 1259 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current maturities of long-term debt | **94** | 660 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation, benefits and retirement costs | **825** | 1084 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of accrued product warranty | **693** | 679 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of deferred revenue | **1606** | 1347 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other accrued expenses | **1926** | 1898 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | **9610** | 11234 |
| Long-term liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt | **6792** | 4784 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | **1054** | 1065 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | **3128** | 3149 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $**20584** | $20232 |
| **EQUITY** |  |  |
| Cummins Inc. shareholders' equity |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock, $2.50 par value, 500 shares authorized, 222.5 and 222.5 shares issued | $**2673** | $2636 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | **22616** | 20828 |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock, at cost, 84.4 and 85.1 shares  | **(10662)** | (10748) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | **(2278)** | (2445) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Cummins Inc. shareholders' equity | **12349** | 10271 |
| Noncontrolling interests | **1059** | 1037 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | $**13408** | $11308 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and equity | $**33992** | $31540 |
| <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. | <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. | <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. |

---

------

**CUMMINS INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited) (a)**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **December 31,** | **December 31,** |
|<br>**In millions** | **2025** | **2024** |
| **NET CASH PROVIDED BY OPERATING ACTIVITIES** | $**1534** | $1422 |
| **CASH FLOWS FROM INVESTING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | **(544)** | (540) |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in and net advances to equity investees | **(133)** | (81) |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in marketable securities—acquisitions | **(494)** | (438) |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in marketable securities—liquidations | **319** | 347 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | **(33)** | (1) |
| Net cash used in investing activities | **(885)** | (713) |
| **CASH FLOWS FROM FINANCING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from borrowings | **103** | 97 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net borrowings of commercial paper | **—** | (377) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on borrowings and finance lease obligations | **(148)** | (182) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend payments on common stock | **(277)** | (250) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments for purchase of redeemable noncontrolling interests | **(55)** | (50) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | **8** | 25 |
| Net cash used in financing activities | **(369)** | (737) |
| **EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS** | **(1)** | (34) |
| Net increase (decrease) in cash and cash equivalents | **279** | (62) |
| Cash and cash equivalents at beginning of period | **2566** | 1733 |
| **CASH AND CASH EQUIVALENTS AT END OF PERIOD** | $**2845** | $1671 |
| <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. | <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. |  |

---

------

**CUMMINS INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** 

**(Unaudited) (a)**

---

| | | |
|:---|:---|:---|
| | **Years ended December 31,** | **Years ended December 31,** |
|<br>**In millions** | **2025** | **2024** |
| **NET CASH PROVIDED BY OPERATING ACTIVITIES** | $**3621** | $1487 |
| **CASH FLOWS FROM INVESTING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | **(1235)** | (1208) |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in and net advances to equity investees | **(196)** | (214) |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition of businesses, net of cash acquired | **(12)** | (58) |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in marketable securities—acquisitions | **(1627)** | (1500) |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in marketable securities—liquidations | **1450** | 1460 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash associated with Atmus divestiture | **—** | (174) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | **(111)** | (88) |
| Net cash used in investing activities | **(1731)** | (1782) |
| **CASH FLOWS FROM FINANCING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from borrowings | **2335** | 2720 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net payments of commercial paper | **(906)** | (237) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on borrowings and finance lease obligations | **(975)** | (1568) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend payments on common stock | **(1055)** | (969) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments for purchase of redeemable noncontrolling interests | **(110)** | (50) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | **(61)** | (69) |
| Net cash used in financing activities | **(772)** | (173) |
| **EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS** | **56** | (40) |
| Net increase (decrease) in cash and cash equivalents | **1174** | (508) |
| Cash and cash equivalents at beginning of year | **1671** | 2179 |
| **CASH AND CASH EQUIVALENTS AT END OF PERIOD** | $**2845** | $1671 |
| <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. | <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. | <sup>(a)</sup> Prepared on an unaudited basis in accordance with accounting principles generally accepted in the United States of America. |

---

------

**CUMMINS INC. AND SUBSIDIARIES**

**SEGMENT INFORMATION**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **In millions** | **Engine** | **Components** | **Distribution** | **Power Systems** | **Accelera** | | **Total Segments** | **Intersegment Eliminations** <sup>(1)</sup> | **Total** |
| **Three months ended December 31, 2025** | | | | | | | | | |
| External sales | $**1980** | $**2092** | $**3280** | $**1062** | $**122** |  | $**8536** | $**—** | $**8536** |
| Intersegment sales | **620** | **353** | **5** | **867** | **9** |  | **1854** | **(1854)** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | **2600** | **2445** | **3285** | **1929** | **131** |  | **10390** | **(1854)** | **8536** |
| Research, development and engineering expenses | **159** | **58** | **11** | **65** | **57** | <sup>(2)</sup> | **350** | **—** | **350** |
| Equity, royalty and interest income (loss) from investees | **67** | **7** | **28** | **27** | **(13)** |  | **116** | **—** | **116** |
| EBITDA <sup>(3)</sup> | **263** | **327** | **495** | **418** | **(374)** | <sup>(2)</sup> | **1129** | **22** | **1151** |
| Depreciation and amortization <sup>(4)</sup> | **70** | **125** | **33** | **36** | **14** |  | **278** | **—** | **278** |
| EBITDA as a percentage of segment sales | **10.1%** | **13.4%** | **15.1%** | **21.7%** | **NM** |  | **10.9%** |  | **13.5%** |
| **Three months ended December 31, 2024** |  |  |  |  |  |  |  |  |  |
| External sales | $2064 | $2247 | $3060 | $992 | $84 |  | $8447 | $— | $8447 |
| Intersegment sales | 656 | 394 | 8 | 751 | 16 |  | 1825 | (1825) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | 2720 | 2641 | 3068 | 1743 | 100 |  | 10272 | (1825) | 8447 |
| Research, development and engineering expenses | 148 | 78 | 14 | 56 | 60 | <sup>(5)</sup> | 356 |  | 356 |
| Equity, royalty and interest income (loss) from investees | 54 | 13 | 17 | 14 | (28) | <sup>(5)</sup> | 70 |  | 70 |
| EBITDA <sup>(3)</sup> | 367 | 361 | 400 | 314 | (431) | <sup>(5)</sup> | 1011 | 9 | 1020 |
| Depreciation and amortization <sup>(4)</sup> | 64 | 126 | 31 | 32 | 16 |  | 269 |  | 269 |
| EBITDA as a percentage of segment sales | 13.5% | 13.7% | 13.0% | 18.0% | NM |  | 9.8% |  | 12.1% |
| "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information |
| <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the three months ended December 31, 2025 and 2024. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the three months ended December 31, 2025 and 2024. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the three months ended December 31, 2025 and 2024. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the three months ended December 31, 2025 and 2024. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the three months ended December 31, 2025 and 2024. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the three months ended December 31, 2025 and 2024. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the three months ended December 31, 2025 and 2024. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the three months ended December 31, 2025 and 2024. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the three months ended December 31, 2025 and 2024. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the three months ended December 31, 2025 and 2024. |
| <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $218 million of charges in EBITDA, related to Accelera actions in the fourth quarter of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $218 million of charges in EBITDA, related to Accelera actions in the fourth quarter of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $218 million of charges in EBITDA, related to Accelera actions in the fourth quarter of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $218 million of charges in EBITDA, related to Accelera actions in the fourth quarter of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $218 million of charges in EBITDA, related to Accelera actions in the fourth quarter of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $218 million of charges in EBITDA, related to Accelera actions in the fourth quarter of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $218 million of charges in EBITDA, related to Accelera actions in the fourth quarter of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $218 million of charges in EBITDA, related to Accelera actions in the fourth quarter of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $218 million of charges in EBITDA, related to Accelera actions in the fourth quarter of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $218 million of charges in EBITDA, related to Accelera actions in the fourth quarter of 2025. See footnote below for additional information. |
| <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. |
| <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in our *Condensed Consolidated Statements of Net Income* as interest expense. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in our *Condensed Consolidated Statements of Net Income* as interest expense. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in our *Condensed Consolidated Statements of Net Income* as interest expense. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in our *Condensed Consolidated Statements of Net Income* as interest expense. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in our *Condensed Consolidated Statements of Net Income* as interest expense. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in our *Condensed Consolidated Statements of Net Income* as interest expense. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in our *Condensed Consolidated Statements of Net Income* as interest expense. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in our *Condensed Consolidated Statements of Net Income* as interest expense. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in our *Condensed Consolidated Statements of Net Income* as interest expense. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in our *Condensed Consolidated Statements of Net Income* as interest expense. A portion of depreciation expense is included in research, development and engineering expenses. |
| <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera actions in the fourth quarter of 2024. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera actions in the fourth quarter of 2024. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera actions in the fourth quarter of 2024. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera actions in the fourth quarter of 2024. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera actions in the fourth quarter of 2024. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera actions in the fourth quarter of 2024. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera actions in the fourth quarter of 2024. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera actions in the fourth quarter of 2024. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera actions in the fourth quarter of 2024. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera actions in the fourth quarter of 2024. |

---

------

**CUMMINS INC. AND SUBSIDIARIES**

**SEGMENT INFORMATION**

**(Unaudited)**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **In millions** | **Engine** | **Components** | | **Distribution** | **Power Systems** | **Accelera** | | **Total Segments** | **Intersegment Eliminations** <sup>(1)</sup> | **Total** |
| **Year ended December 31, 2025** | | | | | | | | | | |
| External sales | $**8104** | $**8643** |  | $**12386** | $**4114** | $**423** |  | $**33670** | $**—** | $**33670** |
| Intersegment sales | **2771** | **1506** |  | **19** | **3349** | **37** |  | **7682** | **(7682)** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | **10875** | **10149** |  | **12405** | **7463** | **460** |  | **41352** | **(7682)** | **33670** |
| Research, development and engineering expenses | **624** | **280** |  | **53** | **253** | **186** | <sup>(2)</sup> | **1396** | **—** | **1396** |
| Equity, royalty and interest income (loss) from investees | **254** | **31** |  | **105** | **109** | **(30)** |  | **469** | **—** | **469** |
| EBITDA <sup>(3)</sup> | **1382** | **1398** |  | **1808** | **1694** | **(896)** | <sup>(2)</sup> | **5386** | **(1)** | **5385** |
| Depreciation and amortization <sup>(4)</sup> | **276** | **496** |  | **129** | **140** | **52** |  | **1093** | **—** | **1093** |
| EBITDA as a percentage of total sales | **12.7%** | **13.8%** |  | **14.6%** | **22.7%** | **NM** |  | **13.0%** |  | **16.0%** |
| **Year ended December 31, 2024** |  |  |  |  |  |  |  |  |  |  |
| External sales | $8987 | $9894 |  | $11352 | $3500 | $369 |  | $34102 | $— | $34102 |
| Intersegment sales | 2725 | 1785 |  | 32 | 2908 | 45 |  | 7495 | (7495) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | 11712 | 11679 |  | 11384 | 6408 | 414 |  | 41597 | (7495) | 34102 |
| Research, development and engineering expenses | 616 | 328 |  | 55 | 236 | 226 | <sup>(5)</sup> | 1461 | 2 | 1463 |
| Equity, royalty and interest income (loss) from investees | 212 | 64 |  | 90 | 79 | (50) | <sup>(5)</sup> | 395 |  | 395 |
| EBITDA <sup>(3)</sup> | 1653 | 1591 | <sup>(6)</sup> | 1378 | 1180 | (764) | <sup>(5)</sup> | 5038 | 1288 | 6326 |
| Depreciation and amortization <sup>(4)</sup> | 245 | 493 |  | 123 | 131 | 61 |  | 1053 |  | 1053 |
| EBITDA as a percentage of total sales | 14.1% | 13.6% |  | 12.1% | 18.4% | NM |  | 12.1% |  | 18.6% |
| "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information | "NM" - not meaningful information |
| <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the twelve months ended December 31, 2025. The twelve months ended December 31, 2024, included a $1.3 billion gain related to the divestiture of Atmus Filtration Technologies Inc. (Atmus) and $14 million of costs associated with the divestiture of Atmus. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the twelve months ended December 31, 2025. The twelve months ended December 31, 2024, included a $1.3 billion gain related to the divestiture of Atmus Filtration Technologies Inc. (Atmus) and $14 million of costs associated with the divestiture of Atmus. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the twelve months ended December 31, 2025. The twelve months ended December 31, 2024, included a $1.3 billion gain related to the divestiture of Atmus Filtration Technologies Inc. (Atmus) and $14 million of costs associated with the divestiture of Atmus. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the twelve months ended December 31, 2025. The twelve months ended December 31, 2024, included a $1.3 billion gain related to the divestiture of Atmus Filtration Technologies Inc. (Atmus) and $14 million of costs associated with the divestiture of Atmus. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the twelve months ended December 31, 2025. The twelve months ended December 31, 2024, included a $1.3 billion gain related to the divestiture of Atmus Filtration Technologies Inc. (Atmus) and $14 million of costs associated with the divestiture of Atmus. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the twelve months ended December 31, 2025. The twelve months ended December 31, 2024, included a $1.3 billion gain related to the divestiture of Atmus Filtration Technologies Inc. (Atmus) and $14 million of costs associated with the divestiture of Atmus. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the twelve months ended December 31, 2025. The twelve months ended December 31, 2024, included a $1.3 billion gain related to the divestiture of Atmus Filtration Technologies Inc. (Atmus) and $14 million of costs associated with the divestiture of Atmus. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the twelve months ended December 31, 2025. The twelve months ended December 31, 2024, included a $1.3 billion gain related to the divestiture of Atmus Filtration Technologies Inc. (Atmus) and $14 million of costs associated with the divestiture of Atmus. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the twelve months ended December 31, 2025. The twelve months ended December 31, 2024, included a $1.3 billion gain related to the divestiture of Atmus Filtration Technologies Inc. (Atmus) and $14 million of costs associated with the divestiture of Atmus. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the twelve months ended December 31, 2025. The twelve months ended December 31, 2024, included a $1.3 billion gain related to the divestiture of Atmus Filtration Technologies Inc. (Atmus) and $14 million of costs associated with the divestiture of Atmus. | <sup>(1)</sup> Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses. There were no significant unallocated corporate expenses for the twelve months ended December 31, 2025. The twelve months ended December 31, 2024, included a $1.3 billion gain related to the divestiture of Atmus Filtration Technologies Inc. (Atmus) and $14 million of costs associated with the divestiture of Atmus. |
| <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $458 million of charges in EBITDA, related to Accelera actions in the second half of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $458 million of charges in EBITDA, related to Accelera actions in the second half of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $458 million of charges in EBITDA, related to Accelera actions in the second half of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $458 million of charges in EBITDA, related to Accelera actions in the second half of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $458 million of charges in EBITDA, related to Accelera actions in the second half of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $458 million of charges in EBITDA, related to Accelera actions in the second half of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $458 million of charges in EBITDA, related to Accelera actions in the second half of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $458 million of charges in EBITDA, related to Accelera actions in the second half of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $458 million of charges in EBITDA, related to Accelera actions in the second half of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $458 million of charges in EBITDA, related to Accelera actions in the second half of 2025. See footnote below for additional information. | <sup>(2)</sup> Included $7 million of charges in research, development and engineering expenses and $458 million of charges in EBITDA, related to Accelera actions in the second half of 2025. See footnote below for additional information. |
| <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. | <sup>(3)</sup> EBITDA is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests. We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. |
| <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excluded the amortization of debt discount and deferred costs included in the *Condensed Consolidated Statements of Net Income* as interest expense. The amortization of debt discount and deferred costs was $12 million and $12 million for the year ended December 31, 2025 and 2024, respectively. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excluded the amortization of debt discount and deferred costs included in the *Condensed Consolidated Statements of Net Income* as interest expense. The amortization of debt discount and deferred costs was $12 million and $12 million for the year ended December 31, 2025 and 2024, respectively. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excluded the amortization of debt discount and deferred costs included in the *Condensed Consolidated Statements of Net Income* as interest expense. The amortization of debt discount and deferred costs was $12 million and $12 million for the year ended December 31, 2025 and 2024, respectively. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excluded the amortization of debt discount and deferred costs included in the *Condensed Consolidated Statements of Net Income* as interest expense. The amortization of debt discount and deferred costs was $12 million and $12 million for the year ended December 31, 2025 and 2024, respectively. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excluded the amortization of debt discount and deferred costs included in the *Condensed Consolidated Statements of Net Income* as interest expense. The amortization of debt discount and deferred costs was $12 million and $12 million for the year ended December 31, 2025 and 2024, respectively. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excluded the amortization of debt discount and deferred costs included in the *Condensed Consolidated Statements of Net Income* as interest expense. The amortization of debt discount and deferred costs was $12 million and $12 million for the year ended December 31, 2025 and 2024, respectively. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excluded the amortization of debt discount and deferred costs included in the *Condensed Consolidated Statements of Net Income* as interest expense. The amortization of debt discount and deferred costs was $12 million and $12 million for the year ended December 31, 2025 and 2024, respectively. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excluded the amortization of debt discount and deferred costs included in the *Condensed Consolidated Statements of Net Income* as interest expense. The amortization of debt discount and deferred costs was $12 million and $12 million for the year ended December 31, 2025 and 2024, respectively. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excluded the amortization of debt discount and deferred costs included in the *Condensed Consolidated Statements of Net Income* as interest expense. The amortization of debt discount and deferred costs was $12 million and $12 million for the year ended December 31, 2025 and 2024, respectively. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excluded the amortization of debt discount and deferred costs included in the *Condensed Consolidated Statements of Net Income* as interest expense. The amortization of debt discount and deferred costs was $12 million and $12 million for the year ended December 31, 2025 and 2024, respectively. A portion of depreciation expense is included in research, development and engineering expenses. | <sup>(4)</sup> Depreciation and amortization, as shown on a segment basis, excluded the amortization of debt discount and deferred costs included in the *Condensed Consolidated Statements of Net Income* as interest expense. The amortization of debt discount and deferred costs was $12 million and $12 million for the year ended December 31, 2025 and 2024, respectively. A portion of depreciation expense is included in research, development and engineering expenses. |
| <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera strategic reorganization actions in the fourth quarter of 2024. See footnote below for additional information. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera strategic reorganization actions in the fourth quarter of 2024. See footnote below for additional information. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera strategic reorganization actions in the fourth quarter of 2024. See footnote below for additional information. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera strategic reorganization actions in the fourth quarter of 2024. See footnote below for additional information. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera strategic reorganization actions in the fourth quarter of 2024. See footnote below for additional information. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera strategic reorganization actions in the fourth quarter of 2024. See footnote below for additional information. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera strategic reorganization actions in the fourth quarter of 2024. See footnote below for additional information. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera strategic reorganization actions in the fourth quarter of 2024. See footnote below for additional information. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera strategic reorganization actions in the fourth quarter of 2024. See footnote below for additional information. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera strategic reorganization actions in the fourth quarter of 2024. See footnote below for additional information. | <sup>(5)</sup> Included $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees and $312 million of charges in EBITDA, all related to Accelera strategic reorganization actions in the fourth quarter of 2024. See footnote below for additional information. |
| <sup>(6)</sup> Included $21 million of costs associated with the divestiture of Atmus for the twelve months ended December 31, 2024. | <sup>(6)</sup> Included $21 million of costs associated with the divestiture of Atmus for the twelve months ended December 31, 2024. | <sup>(6)</sup> Included $21 million of costs associated with the divestiture of Atmus for the twelve months ended December 31, 2024. | <sup>(6)</sup> Included $21 million of costs associated with the divestiture of Atmus for the twelve months ended December 31, 2024. | <sup>(6)</sup> Included $21 million of costs associated with the divestiture of Atmus for the twelve months ended December 31, 2024. | <sup>(6)</sup> Included $21 million of costs associated with the divestiture of Atmus for the twelve months ended December 31, 2024. | <sup>(6)</sup> Included $21 million of costs associated with the divestiture of Atmus for the twelve months ended December 31, 2024. | <sup>(6)</sup> Included $21 million of costs associated with the divestiture of Atmus for the twelve months ended December 31, 2024. | <sup>(6)</sup> Included $21 million of costs associated with the divestiture of Atmus for the twelve months ended December 31, 2024. | <sup>(6)</sup> Included $21 million of costs associated with the divestiture of Atmus for the twelve months ended December 31, 2024. | <sup>(6)</sup> Included $21 million of costs associated with the divestiture of Atmus for the twelve months ended December 31, 2024. |

---

------

**CUMMINS INC. AND SUBSIDIARIES**

**SELECT FOOTNOTE DATA**

**(Unaudited)**

**EQUITY, ROYALTY AND INTEREST INCOME FROM INVESTEES**

Equity, royalty and interest income from investees included in our *Condensed Consolidated Statements of Net Income* for the reporting periods was as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended December 31,** | **Three months ended December 31,** | | **Years ended December 31,** | **Years ended December 31,** | |
| **In millions** | **2025** | **2024** |  | **2025** | **2024** |  |
| **Manufacturing entities** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Chongqing Cummins Engine Company, Ltd. | $**21** | $9 |  | $**89** | $60 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dongfeng Cummins Engine Company, Ltd. | **18** | 15 |  | **70** | 66 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beijing Foton Cummins Engine Co., Ltd. | **17** | 13 |  | **64** | 42 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Tata Cummins, Ltd. | **10** | 9 |  | **33** | 31 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;All other manufacturers | **2** | (16) | <sup>(1)</sup> | **29** | 25 | <sup>(1)</sup> |
| **Distribution entities** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Komatsu Cummins Chile, Ltda. | **13** | 13 |  | **54** | 55 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;All other distributors | **8** | 7 |  | **25** | 17 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cummins share of net income | **89** | 50 |  | **364** | 296 |  |
| **Royalty and interest income** | **27** | 20 |  | **105** | 99 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity, royalty and interest income from investees | $**116** | $70 |  | $**469** | $395 |  |
| <sup>(1)</sup> Included $17 million of charges in equity, royalty and interest income (loss) from investees related to the Accelera strategic reorganization actions in the fourth quarter of 2024. | <sup>(1)</sup> Included $17 million of charges in equity, royalty and interest income (loss) from investees related to the Accelera strategic reorganization actions in the fourth quarter of 2024. | <sup>(1)</sup> Included $17 million of charges in equity, royalty and interest income (loss) from investees related to the Accelera strategic reorganization actions in the fourth quarter of 2024. | <sup>(1)</sup> Included $17 million of charges in equity, royalty and interest income (loss) from investees related to the Accelera strategic reorganization actions in the fourth quarter of 2024. | <sup>(1)</sup> Included $17 million of charges in equity, royalty and interest income (loss) from investees related to the Accelera strategic reorganization actions in the fourth quarter of 2024. | <sup>(1)</sup> Included $17 million of charges in equity, royalty and interest income (loss) from investees related to the Accelera strategic reorganization actions in the fourth quarter of 2024. |  |

---

**ACCELERA ACTIONS**

During the third quarter of 2025, in our Accelera segment, we observed rapidly deteriorating conditions in our electrolyzer markets and overall hydrogen markets, along with significant uncertainty in the alternative power markets resulting from reductions in government incentives. As a result, we determined that a triggering event occurred for our electrolyzer reporting unit, warranting an interim impairment test of goodwill and the related asset group. We also re-evaluated the recoverability of certain inventory in this business due to the declining customer demand, resulting in a $30 million excess and obsolete inventory write-down. We concluded that the undiscounted cash flows exceeded the carrying value of the related asset group and thus an impairment did not exist for the related long-lived assets. However, we determined that on a fair value basis our goodwill was fully impaired and recorded a charge of $210 million. The fair value of this reporting unit was determined using primarily a discounted cash flow model (a form of the income approach). This model incorporated a number of assumptions and judgements surrounding current market and economic conditions, internal forecasts of future business performance including short and long-term growth rates, earnings or losses before interest expense, income taxes, depreciation and amortization and noncontrolling interests (EBITDA) margins and discount rates.

The continuing deterioration in the electrolyzer markets in the fourth quarter of 2025, prompted a strategic review of this business. As a result of these market conditions and the current business outlook, we intend to stop new commercial activity in the electrolyzer space, subject to information and consultation in accordance with local legal requirements. We will continue to fulfill existing customer commitments. As a result of this shift, we recorded several non-cash charges in the fourth quarter related to inventory write-downs along with intangible and fixed asset impairments. We also recorded severance of approximately $13 million and contract termination costs of $34 million. Total charges for the fourth quarter actions were $218 million, or $1.54 per diluted share.

------

**CUMMINS INC. AND SUBSIDIARIES**

**SELECT FOOTNOTE DATA**

**(Unaudited)**

The following table presents the impact of these actions on our *Condensed Consolidated Statements of Net Income:*

---

| | | |
|:---|:---|:---|
| | **Year ended** | |
|<br>**In millions** | **December 31,<br>2025** |<br>**Statement of Net Income Location** |
| Impairment of goodwill | $**210** | Other operating expense, net |
| Inventory write-downs | **119** | Cost of sales |
| Impairment of property, plant and equipment and leases | **55** | Other operating expense, net |
| Contract termination costs | **34** | Cost of sales |
| Impairment of other intangible assets | **27** | Other operating expense, net |
| Severance | **13** | Cost of sales, selling, general and administrative expenses and research, development and engineering expenses |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $**458** |  |

---

The majority of the $458 million is reflected in net cash provided by operating activities, as a change in inventory of $119 million and other, net of $292 million. Of the $458 million, $415 million were non-cash charges and the majority of the remaining $43 million cash charge will be paid during 2026. Of the total charges, approximately $445 million occurred in jurisdictions where we receive no tax benefits because of valuation allowances or the charges are attributable to nondeductible goodwill.

**INCOME TAXES**

On July 4, 2025, The Act was signed into law, enacting significant changes to U.S. federal income tax rules affecting corporations, such as the ability to immediately deduct domestic research and development costs, restoration of elective 100 percent bonus depreciation for qualified property and changes to the international tax provisions. Implementation of The Act resulted in an increase to tax expense of $39 million in the second half of 2025, primarily due to a reduction in the foreign income deduction and changes to the research and development tax credit. Additionally, certain provisions of The Act resulted in lower U.S. tax-related cash payments in 2025 and should result in lower U.S. tax-related payments for the next several fiscal years.

Our effective tax rate for 2026, excluding discrete items, is expected to approximate 24.0 percent.

Our effective tax rates for the three and twelve months ended December 31, 2025, were 21.6 percent and 25.4 percent, respectively. Our effective tax rates for the three and twelve months ended December 31, 2024, were 32.8 percent and 17.0 percent, respectively.

The three months ended December 31, 2025, contained net favorable discrete tax items of $69 million, or $0.50 per diluted share, primarily due to $39 million of favorable return to provision adjustments, $21 million of favorable adjustments for uncertain tax positions, $3 million of favorable adjustments for share-based compensation and $6 million of other favorable tax items.

The year ended December 31, 2025, contained net favorable discrete tax items of $75 million, or $0.54, per diluted share, primarily due to $51 million of favorable adjustments for uncertain tax positions and $15 million of favorable adjustments for share-based compensation, $7 million of favorable return to provision adjustments and $2 million of other favorable adjustments.

The three months ended December 31, 2024, contained net unfavorable discrete tax items of $7 million, or $0.05 per diluted share, primarily due to $50 million of unfavorable adjustments related to Accelera strategic reorganization actions, partially offset by $34 million of favorable return to provision adjustments and net $9 million of other favorable adjustments.

The year ended December 31, 2024, contained net favorable discrete tax items primarily due to the $1.3 billion non-taxable gain on the Atmus split-off. Other discrete tax items were net favorable by $59 million, or $0.42 per diluted share, primarily due to $52 million of favorable return to provision adjustments, $22 million of favorable share-based compensation tax benefits, $21 million of favorable adjustments related to audit settlements and $20 million of favorable adjustments from tax return amendments, partially offset by $50 million of unfavorable adjustments related to Accelera strategic reorganization actions and a net $6 million of other unfavorable adjustments.

------

**CUMMINS INC. AND SUBSIDIARIES**

**SELECT FOOTNOTE DATA**

**(Unaudited)**

**Reconciliation of Non GAAP measures - Earnings before interest, income taxes, depreciation and amortization and noncontrolling interests (EBITDA)**

We believe EBITDA is a useful measure of our operating performance as it assists investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. We believe EBITDA excluding special items, as noted in the table below, is a useful measure of our operating performance. This statement excludes forward looking measures of EBITDA where a reconciliation to the corresponding accounting principles generally accepted in the United States (GAAP) measures is not available due to the variability, complexity and limited visibility of non-cash items that are excluded from the non-GAAP outlook measure.

EBITDA is not in accordance with, or an alternative for, GAAP and may not be consistent with measures used by other companies. It should be considered supplemental data; however, the amounts included in the EBITDA calculation are derived from amounts included in our *Condensed Consolidated Statements of Net Income.* Below is a reconciliation of net income attributable to Cummins Inc. to EBITDA for each of the applicable periods:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended December 31,** | **Three months ended December 31,** | **Years ended December 31,** | **Years ended December 31,** |
|<br>**In millions** | **2025** | **2024** | **2025** | **2024** |
| Net income attributable to Cummins Inc. | $**593** | $418 | $**2843** | $3946 |
| *Net income attributable to Cummins Inc., as a percentage of net sales* | ***6.9*** *%*** | *4.9 %* | ***8.4*** *%*** | *11.6 %* |
| Add: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interests | **27** | 27 | **114** | 122 |
| Consolidated net income | **620** | 445 | **2957** | 4068 |
| Add: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | **82** | 89 | **329** | 370 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | **171** | 217 | **1006** | 835 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | **278** | 269 | **1093** | 1053 |
| EBITDA | $**1151** | $1020 | $**5385** | $6326 |
| *EBITDA, as a percentage of net sales* | ***13.5*** *%*** | *12.1 %* | ***16.0*** *%*** | *18.6 %* |
| Special items: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accelera actions | **218** | 312 | **458** | 312 |
| &nbsp;&nbsp;&nbsp;&nbsp;Atmus divestiture costs | **—** |  | **—** | 35 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring actions | **—** |  | **—** | 29 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain related to the divestiture of Atmus | **—** |  | **—** | (1333) |
| EBITDA, excluding special items | $**1369** | $1332 | $**5843** | $5369 |
| *EBITDA, excluding special items, as a percentage of net sales* | ***16.0*** *%*** | *15.8 %* | ***17.4*** *%*** | *15.7 %* |

---

------

**CUMMINS INC. AND SUBSIDIARIES**

**SEGMENT SALES DATA** 

**(Unaudited)**

**Engine Segment Sales by Market and Unit Shipments by Engine Classification**

Sales for our Engine segment by market were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **2025** |  |  |  |  |  |
| **In millions** | **Q1** | **Q2** | **Q3** | **Q4** | **YTD** |
| Heavy-duty truck | $921 | $976 | $772 | $**820** | $3489 |
| Medium-duty truck and bus | 986 | 950 | 784 | **893** | 3613 |
| Light-duty automotive | 421 | 486 | 583 | **440** | 1930 |
| Off-highway | 443 | 487 | 466 | **447** | 1843 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | $2771 | $2899 | $2605 | $**2600** | $10875 |
| **2024** |  |  |  |  |  |
| **In millions** | **Q1** | **Q2** | **Q3** | **Q4** | **YTD** |
| Heavy-duty truck | $1059 | $1184 | $1021 | $980 | $4244 |
| Medium-duty truck and bus | 995 | 1074 | 1073 | 1024 | 4166 |
| Light-duty automotive | 438 | 461 | 395 | 301 | 1595 |
| Off-highway | 436 | 432 | 424 | 415 | 1707 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | $2928 | $3151 | $2913 | $2720 | $11712 |

---

Unit shipments by engine classification (including unit shipments to Power Systems and off-highway engine units included in their respective classification) were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **2025** |  |  |  |  |  |
| **Units** <sup>(1)</sup> | **Q1** | **Q2** | **Q3** | **Q4** | **YTD** |
| Heavy-duty | 26700 | 29600 | 22400 | **23200** | 101900 |
| Medium-duty | 75200 | 73400 | 63100 | **68800** | 280500 |
| Light-duty | 39100 | 44000 | 49600 | **39100** | 171800 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total units | 141000 | 147000 | 135100 | **131100** | 554200 |
| **2024** |  |  |  |  |  |
| **Units** <sup>(1)</sup> | **Q1** | **Q2** | **Q3** | **Q4** | **YTD** |
| Heavy-duty | 33600 | 37500 | 32400 | 29400 | 132900 |
| Medium-duty | 75800 | 79600 | 79200 | 75700 | 310300 |
| Light-duty | 54800 | 57200 | 41400 | 36000 | 189400 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total units | 164200 | 174300 | 153000 | 141100 | 632600 |
| <sup>(1)</sup> Unit shipments exclude aftermarket parts.  | <sup>(1)</sup> Unit shipments exclude aftermarket parts.  | <sup>(1)</sup> Unit shipments exclude aftermarket parts.  | <sup>(1)</sup> Unit shipments exclude aftermarket parts.  | <sup>(1)</sup> Unit shipments exclude aftermarket parts.  | <sup>(1)</sup> Unit shipments exclude aftermarket parts.  |

---

------

**Components Segment Sales by Business**

Sales for our Components segment by business were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **2025** |  |  |  |  |  |
| **In millions** | **Q1** | **Q2** | **Q3** | **Q4** | **YTD** |
| Drivetrain and braking systems | $1056 | $1095 | $917 | $**918** | $3986 |
| Emission solutions | 902 | 900 | 788 | **867** | 3457 |
| Components and software | 595 | 587 | 537 | **564** | 2283 |
| Automated transmissions | 117 | 123 | 87 | **96** | 423 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | $2670 | $2705 | $2329 | $**2445** | $10149 |
| **2024** |  |  |  |  |  |
| **In millions** | **Q1** | **Q2** | **Q3** | **Q4** | **YTD** |
| Drivetrain and braking systems | $1232 | $1256 | $1131 | $1114 | $4733 |
| Emission solutions | 971 | 941 | 864 | 825 | 3601 |
| Components and software | 611 | 623 | 581 | 589 | 2404 |
| Automated transmissions | 165 | 162 | 148 | 113 | 588 |
| Atmus <sup>(1)</sup> | 353 |  |  |  | 353 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | $3332 | $2982 | $2724 | $2641 | $11679 |
| <sup>(1)</sup> Included sales through the March 18, 2024, divestiture.  | <sup>(1)</sup> Included sales through the March 18, 2024, divestiture.  | <sup>(1)</sup> Included sales through the March 18, 2024, divestiture.  | <sup>(1)</sup> Included sales through the March 18, 2024, divestiture.  | <sup>(1)</sup> Included sales through the March 18, 2024, divestiture.  | <sup>(1)</sup> Included sales through the March 18, 2024, divestiture.  |

---

**Distribution Segment Sales by Product Line**

Sales for our Distribution segment by product line were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **2025** |  |  |  |  |  |
| **In millions** | **Q1** | **Q2** | **Q3** | **Q4** | **YTD** |
| Power generation | $1090 | $1200 | $1247 | $**1395** | $4932 |
| Parts | 1031 | 1015 | 1013 | **1024** | 4083 |
| Service | 416 | 439 | 495 | **448** | 1798 |
| Engines | 370 | 387 | 417 | **418** | 1592 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | $2907 | $3041 | $3172 | $**3285** | $12405 |
| **2024** |  |  |  |  |  |
| **In millions** | **Q1** | **Q2** | **Q3** | **Q4** | **YTD** |
| Power generation | $707 | $954 | $1091 | $1220 | $3972 |
| Parts | 1001 | 990 | 1004 | 985 | 3980 |
| Service | 406 | 448 | 455 | 444 | 1753 |
| Engines | 421 | 437 | 402 | 419 | 1679 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | $2535 | $2829 | $2952 | $3068 | $11384 |

---

------

**Power Systems Segment Sales by Product Line**

Sales for our Power Systems segment by product line were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **2025** |  |  |  |  |  |
| **In millions** | **Q1** | **Q2** | **Q3** | **Q4** | **YTD** |
| Power generation | $1001 | $1205 | $1280 | $**1245** | $4731 |
| Industrial | 498 | 506 | 531 | **528** | 2063 |
| Generator technologies | 150 | 178 | 185 | **156** | 669 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | $1649 | $1889 | $1996 | $**1929** | $7463 |
| **2024** |  |  |  |  |  |
| **In millions** | **Q1** | **Q2** | **Q3** | **Q4** | **YTD** |
| Power generation | $853 | $987 | $1055 | $1090 | $3985 |
| Industrial | 420 | 478 | 508 | 526 | 1932 |
| Generator technologies | 116 | 124 | 124 | 127 | 491 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | $1389 | $1589 | $1687 | $1743 | $6408 |

---

<br>